Patient characteristics
| . | BEAM-Campath, n = 18 . | Fludarabine-based conditioning,* n = 18 . |
|---|---|---|
| Male/Female | 15/3 | 12/6 |
| Median age, y (range) | 48.7 (23.6-59.5) | 51.8 (31.8-59.9) |
| Diagnosis | ||
| AML | 0 | 3 |
| MM | 0 | 3 |
| Lymphoma/CLL | 18 | 7 |
| CML/MPD | 0 | 4 |
| MDS | 0 | 1 |
| HLA compatibility | ||
| HLA-matched relative | 14 | 5 |
| 1 antigen mismatch sibling | 4 | 2 |
| Matched unrelated donor | 0 | 11 |
| . | BEAM-Campath, n = 18 . | Fludarabine-based conditioning,* n = 18 . |
|---|---|---|
| Male/Female | 15/3 | 12/6 |
| Median age, y (range) | 48.7 (23.6-59.5) | 51.8 (31.8-59.9) |
| Diagnosis | ||
| AML | 0 | 3 |
| MM | 0 | 3 |
| Lymphoma/CLL | 18 | 7 |
| CML/MPD | 0 | 4 |
| MDS | 0 | 1 |
| HLA compatibility | ||
| HLA-matched relative | 14 | 5 |
| 1 antigen mismatch sibling | 4 | 2 |
| Matched unrelated donor | 0 | 11 |
AML indicates acute myeloid leukemia; MM, multiple myeloma; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; MPD, myeloproliferative disease; and MDS, myelodysplastic syndrome.
Flu BEAM-Campath or FMC.